Fulgent Genetics Financial Overview
Fulgent Genetics's market cap is currently $853.49M. The company's EPS TTM is $0.14; its P/E ratio is -19.70; Fulgent Genetics is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
